Cardlytics, Inc.

CDLXNASDAQCommunication Services● Active

$5.78

$-0.20(-3.41%)

Market Cap$332943664

P/E Ratio—

52W High$6.28

52W Low$0.55

Avg Volume1.2M

Open$5.88

Beta0.60

Free Cash Flow Financials Revenue

Cardlytics, Inc. (CDLX) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CDLX · free cash flow · updated Jun 8, 2026

Core FCF metrics

CDLX · FCF · TTM · margin & CAGR

Free cash flow was $8.8M for FY2025 (fiscal year ending 2025-12-31), up 131.3% year-over-year The FCF margin was 3.8%.

FY2025 Free Cash Flow$8.8M▲ +131.3% YoY

Trailing 12M (TTM)$5.9Mtrailing 4 quarters sum

FCF Margin3.8%$8.8M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

CDLX · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$9.3M(0M)$8.8M▲ +131.3%3.8%

FY2024−$8.8M(19M)−$28.1M▼ 123.6%-10.1%

FY2023−$185,000(12M)−$12.6M▲ +81.3%-4.1%

FY2022−$53.9M(13M)−$67.4M▼ 31.9%-22.6%

FY2021−$38.5M(13M)−$51.1M▼ 188.4%-19.1%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

CDLX · P/FCF · FCF yield · FCF per share

Cardlytics, Inc. (CDLX) trades at a FCF yield of 1.71% and a price-to-free-cash-flow ratio of 52.5x. FCF per share stands at $0.11, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

1.71%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.11

TTM FCF ÷ Shares Outstanding

Price / FCF

x52.5

Share Price ÷ FCF per Share

EV / FCF (TTM)

x88.1

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

CDLX · cash flow statement · operating / investing / financing

For FY2025, Cardlytics, Inc. generated $9.3M in operating cash flow and spent 0M in capital expenditures, yielding $8.8M in free cash flow.

Operating Activities

+$9.3M

Cash from core business operations

2025-12-31

Investing Activities

−$15.3M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$11.1M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($9.3M) − |CapEx| (0M) = FCF ($8.8M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Communication Services)

CDLX vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Cardlytics, Inc.YOU

CDLX

$8.8M+131.3%3.8%

About Free Cash Flow & Methodology

Cardlytics, Inc. (CDLX) reported free cash flow of $8.8M for FY2025 (fiscal year ending 2025-12-31), up 131.3% year-over-year. The FCF margin was 3.8%.

Based on available data, Cardlytics, Inc. has maintained positive free cash flow for at least 2 fiscal year(s). FCF peaked at $8.8M in FY2025.

Cardlytics, Inc.'s FCF yield is 1.71% and price-to-FCF ratio is 52.5x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

CDLX free cash flow · 8 questions

Cardlytics, Inc. free cash flow was $8.8M for FY2025, up 131.3% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $5.9M.

CDLX free cash flowCDLX FCFCDLX FCF 2025CDLX free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Cardlytics, Inc. · Cardlytics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026